{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-004016","form_type":"8-K","ticker":"BBNX","cik":"0001674632","company_name":"Beta Bionics, Inc.","filed_at":"2025-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.298578+00:00","generated_at":"2026-05-18T23:51:49.709128+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Beta Bionics reports real-world iLet data: HbA1c drops from 8.9% to 7.3% in 14,952 users","bullets":["16,439 iLet users uploaded data in first 2 years; 14,952 with baseline HbA1c showed avg drop from 8.9% to 7.3% GMI.","8,802 prior MDI users improved from 9.2% to 7.3%; 2,910 prior HCL users improved from 8.1% to 7.3%.","2,416 'fully-closed loop' users (≤1 meal announcement/day) improved from 9.4% to 7.5% GMI; 83% met ADA hypoglycemia goals.","Adaptive algorithm reaches steady state in ~2 days; similar outcomes seen in primary care and endocrinology practices.","Company highlights pharmacy channel strategy and bionic portal for HCPs; no financial guidance provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-004016","json":"https://secwatch.observer/filing/0001171843-25-004016.json","markdown":"https://secwatch.observer/filing/0001171843-25-004016.md","text":"https://secwatch.observer/filing/0001171843-25-004016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325004016/0001171843-25-004016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325004016/f8k_062225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T23:51:49.709128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}